| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | - | 0 | 0 | 11.191 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | - | - | 6.721 | 25.226 | 24.493 | 24.769 | 26.127 | 4.733 | 4.718 | 4.692 |
| Gross Profit/Loss - EUR | - | - | -6.721 | -25.226 | -13.303 | -24.769 | -26.127 | -4.733 | -4.718 | -4.692 |
| Net Profit/Loss - EUR | - | - | -6.835 | -25.226 | -13.303 | -24.769 | -26.127 | -4.733 | -4.718 | -4.692 |
| Employees | - | - | 0 | 3 | 3 | 3 | 3 | 0 | 0 | 0 |
Check the financial reports for the company - Bioderm Maia Noire Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 43.827 | 37.317 | 30.999 | 24.922 | 19.002 | 14.328 | 9.566 | 4.821 |
| Current Assets | - | - | 1.459 | 1.315 | 13.593 | 14.722 | 13.280 | 2.510 | 2.503 | 2.488 |
| Inventories | - | - | 967 | 971 | 953 | 934 | 914 | 917 | 914 | 909 |
| Receivables | - | - | 0 | 0 | 11.191 | 10.978 | 10.735 | 0 | 0 | 0 |
| Cash | - | - | 492 | 344 | 1.450 | 2.809 | 1.631 | 1.593 | 1.589 | 1.580 |
| Shareholders Funds | - | - | -6.791 | -31.892 | -44.577 | -68.501 | -93.108 | -98.130 | -102.551 | -106.669 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 52.077 | 70.524 | 47.115 | 66.888 | 85.048 | 85.269 | 85.011 | 84.536 |
| Income in Advance | - | - | 0 | 0 | 42.054 | 41.257 | 40.342 | 29.699 | 29.609 | 29.443 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2042 - 2042" | |||||||||
| CAEN Financial Year |
2042
|
|||||||||
Comments - Bioderm Maia Noire Srl